News and Announcements
$2.6B Market Breakthrough in Cardiac Technology | EBR Systems
- Published January 29, 2025 1:02AM UTC
- Publisher Maan Perez
- Categories Executive Interviews
Join the conversation with Andrew Shute, SVP of EBR Systems, as we explore the innovative VICRD system, a leadless device poised to transform cardiac resynchronization therapy. Discover its advantages over traditional therapies, a $3.6 billion market potential, and promising clinical outcomes. Learn about EBR Systems’ U.S. expansion strategy, their pioneering rechargeable battery technology, and key milestones ahead. This episode delves into an innovation that not only advances medical technology but also offers new hope for heart failure patients.
Executive Interviews
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Asset over thematic: Centuria’s Andrew Essey warns against ‘blanket strategies’ as global capital eyes Australia
Relying solely on broad macroeconomic trends is the single biggest mistake property investors make today. Centuria Capital CIO Andrew Essey explains why asset-level “lettability” always trumps the overarching sector thematic, and reveals where global institutional capital is quietly pivoting to capture high-octane returns.
Material gains: Swinburne spin-out EntroMat takes aim at $160b global market
Traditional metallurgy has hit a performance wall. Discover how Swinburne University spin-out EntroMat is leveraging physics-based AI and circular critical minerals to engineer high-entropy alloys capable of surviving the world’s most extreme industrial environments.
Backed By Leading Investment Groups and Family Offices
